POSTER SESSION IV & CONTINENTAL BREAKFAST

Wednesday, October 22, 2014: 7:30 AM - 9:00 AM

* Finalists for the Lee B. Lusted Student Prize

PS4-1

GERMS ARE GERMS, AND WHY NOT TAKE A RISK?: PATIENTS' EXPECTATIONS FOR PRESCRIBING ANTIBIOTICS IN AN INNER CITY EMERGENCY DEPARTMENT
David Broniatowski, PhD, The George Washington University, Washington, DC and Valerie Reyna, PhD, Cornell University, Ithaca, NY
PS4-2

* USABILITY TESTING OF A PATIENT EDUCATION TOOL FOR VAGINAL BIRTH AFTER CESAREAN (VBAC)
Sarah Munro, MA1, Kathryn Dewar, PhD2, Asheya Kassner, BEd1, Michael Klein, MD1, Elizabeth Wilcox, MA1 and Patricia Janssen, PhD1, (1)University of British Columbia, Vancouver, BC, Canada, (2)Women's Health Research Institute, Vancouver, BC, Canada
PS4-4

COST-EFFECTIVENESS OF FIRST LINE LPV/R-BASED REGIMEN FOR HIV INFECTED INFANTS IN WESTERN KENYA
S. Maria E. Finnell, MD, MS1, Jason Kessler, M.D., M.P.H2, Lingfeng Li, PhD2, Winstone Nyandiko, MD, MS3, Rachel Vreeman, MD, MS1, Kim Nucifora, MS2, Christopher Toohey, MS2 and R. Scott Braithwaite, MD, MSc, FACP2, (1)Children's Health Services Research, Indiana University School of Medicine, Indianapolis, IN, (2)New York University School of Medicine, New York, NY, (3)Moi University School of Medicine, Eldoret, Kenya
PS4-5

RETURN ON INVESTMENT OF A WORK-FAMILY INTERVENTION: EVIDENCE FROM THE WORK, FAMILY, AND HEALTH NETWORK
Carolina Barbosa, PhD, MSc, PharmD1, Jeremy Bray, PhD2, William Dowd, BA3, Michael Mills, MA3, Mary Durham, PhD4, Brad Wipfli, PhD5, Ryan Olson, PhD5 and Erin Kelly, PhD6, (1)RTI International, Chicago, IL, (2)UNC Greensboro, Greensboro, NC, (3)RTI International, Research Triangle Park, NC, (4)Kaiser Permanente Center for Health Research, Portland, OR, (5)Oregon Health & Science University, Portland, OR, (6)University of Minnesota, Minneapolis, MN
PS4-6

MULTINATIONAL COMPARISON OF VALUES FOR THE 5-LEVEL EQ-5D BASED ON VISUAL ANALOGUE SCALE AND DISCRETE CHOICE MODELING
Elise Quik, PhD, University of Groningen; University Medical Center Groningen, Groningen, Netherlands, Nancy Devlin, PhD, Office of Health Economics, London, United Kingdom, Elly Stolk, PhD, Institute of Health Policy and Management/institute for Medical Technology Assessment Erasmus University, Rotterdam, Netherlands and Paul Krabbe, PhD, University Medical Center Groningen, Groningen, Netherlands
PS4-7

* APPLICATION OF MULTI-CRITERIA DECISION ANALYSIS IN HEALTHCARE: A SYSTEMATIC REVIEW OF THE LITERATURE
Georges Adunlin, MA1, Vakaramoko Diaby, PhD2, Alberto Montero, M.D., MBA3 and Hong Xiao, PhD2, (1)Florida A & M University, Tallahassee, FL, (2)Florida A&M University, Tallahassee, FL, (3)Cleveland Clinic, Taussig Cancer Center Department of Solid Tumor Oncology, Cleveland, OH
PS4-8

THE EVOLUTION OF CHRONIC DISEASE TREATMENT DECISIONS IN PEDIATRICS
Ellen A. Lipstein, MD, MPH and Maria T. Britto, MD, MPH, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
PS4-9

* COST-EFFECTIVENESS OF NOVEL HEPATITIS C REGIMENS IN THE VETERANS HEALTH ADMINISTRATION
Alexis P. Chidi, MSPH1, Shari S. Rogal, MD, MPH2, Cindy L. Bryce, PhD2, Michael J. Fine, MD, MSc3, Chester B. Good, MD, MPH4, Larissa Myaskovsky, PhD1, Allan Tsung, MD2 and Kenneth J. Smith, MD, MS2, (1)University of Pittsburgh, VA Pittsburgh Healthcare System, Pittsburgh, PA, (2)University of Pittsburgh, Pittsburgh, PA, (3)University of Pittsburgh School of Medicine, Pittsburgh, PA, (4)VA Pharmacy Benefits Management Services, Pittsburgh, PA
PS4-10

CORRELATES OF MEDICATION DECISION SELF-EFFICACY AMONG ADOLESCENTS IN PSYCHIATRIC RESIDENTIAL FACILITIES
Kyle Chapman, MA, Michael Rosen, MS and Megan O'Brien, PHD, MPH, University of Kansas, Lawrence, KS
PS4-11

* FRAMEWORKS TO SELECT THE APPROPRIATE MODELLING APPROACH FOR DECISION-ANALYTIC ECONOMIC EVALUATIONS—DO DIFFERENT MODELLING APPROACHES LEAD TO DISPARATE RESULTS?
Bernice Tsoi, BSc, MSc, PhD(cand)1, Jathishinie Jegathisawaran, BMSc, MHEcon2, Jean-Eric Tarride, PhD, MA3, Gord Blackhouse, BA, MBA, MSc4, Daria J. O'Reilly, PhD, MSc5 and Ron Goeree, MA2, (1)Programs for Assessment of Technology in Health (PATH) Research Institute, Dept. of Clinical Epidemiology & Biostatistics,McMaster University, Hamilton, ON, Canada, (2)Programs for Assessment of Technology in Health (PATH) Research Institute, St. Joseph's Healthcare, Hamilton, ON, Canada, (3)McMaster University, Dept. of Clinical Epidemiology & Biostatistics, Hamilton, ON, Canada, (4)McMaster University, Programs for Assessment of Technology in Health (PATH) Research Institute, Dept. of Clinical Epidemiology & Biostatistics, Hamilton, ON, Canada, (5)McMaster University, Hamilton, ON, Canada
PS4-12

DISPARITIES AMONG THOSE WITH ADVANCE DIRECTIVES IN A MEDICARE SUPPLEMENT POPULATION
Kevin Hawkins, PhD, OptumInsight, Ann Arbor, MI
PS4-13

* AN EXAMINATION OF HEALTH TOPICS THAT INFLUENCE HOW THE DIABETES AND HEART DISEASE COMMUNITIES INTERACT ON FACEBOOK
Kristina Birnbrauer, MA and Dennis Frohlich, Ph.D., University of Florida, Gainesville, FL
PS4-14

* THE EFFECTS OF SHARED DECISION MAKING ON CANCER SCREENING: A SYSTEMATIC REVIEW
Sarah Lillie, PhD, MPH1, Melissa Partin, PhD1, Nancy Greer, PhD2, Angela Fabbrini, MPH3, Sagar Patel, MD4, Kathryn Rice, MD3 and Timothy Wilt, MD, MPH1, (1)Minneapolis VAHCS Center for Chronic Disease Outcomes Research, Minneapolis, MN, (2)Minneapolis VAHCS Chronic Disease Outcomes Research, Minneapolis, MN, (3)Minneapolis VAHCS Pulmonary Section, Minneapolis, MN, (4)Minneapolis VAHCS Section of General Internal Medicine, Minneapolis, MN
PS4-15

JAPANESE PHYSICIANS' PREFERENCES FOR DECISION-MAKING IN RHEUMATOID ARTHRITIS TREATMENT
Akiko Aoki, Dr, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan and Sadayoshi Ohbu, Dr, Department of Sociology, Rikkyo University, Tokyo, Japan
PS4-16

EPIDEMIOLOGICAL AND ECONOMIC IMPACT OF MONOVALENT AND PENTAVALENT ROTAVIRUS VACCINES IN LOW AND MIDDLE INCOME COUNTRIES: A COST-EFFECTIVENESS MODELING ANALYSIS
Angel Paternina, MD, MSc, Hospital Infantil Napoleón Franco Pareja, Cartagena de Indias, Colombia, Nelson Alvis-Guzmán, PhD, MPH, MD, Universidad de Cartagena., Colombia, Colombia and Fernando De la Hoz-Restrepo, MD, MPH, PhD, Universidad Nacional de Colombia, Bogota, Colombia
PS4-17

COST-EFFECTIVENESS OF THE SEQUENTIAL APPLICATION OF TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA PATIENTS IN THE UNITED STATES
Martina Kluibenschaedl, Mag.1, Ursula Rochau, MD, MSc2, David Stenehjem, PharmD3, Kuan-Ling Kuo, BSPharm4, Gary Oderda, Prof., PharmD, MPH4, Diana Brixner, Prof., PhD, PharmD5 and Uwe Siebert, Prof., MD, MPH, MSc, ScD6, (1)UMIT - University for Health Sciences, Medical Informatics and Technology, Institute of Public Health, Medical Decision Making and HTA, Department of Public Health and HTA, Hall in Tyrol, Austria, (2)UMIT - University for Health Sciences, Medical Informatics and Technology, Institute of Public Health, Medical Decision Making and HTA, Department of Public Health and HTA/ ONCOTYROL - Center for Personalized Cancer Medicine, Area 4 HTA and Bioinformatics, Hall in Tyrol/ Innsbruck, Austria, (3)University of Utah, Department of Pharmacotherapy and Program in Personalized Health Care/ University of Utah Hospitals & Clinics, Huntsman Cancer Institute, Salt Lake City, UT, (4)University of Utah, Department of Pharmacotherapy and Program in Personalized Health Care, Salt Lake City, UT, (5)UMIT-University for Health Sciences, Medical Informatics&Technology, Dept. Public Health&HTA/ ONCOTYROL - Center for Personalized Cancer Medicine, Area 4 HTA&Bioinformatics/ University of Utah, Dept. Pharmacotherapy&Program in Personalized Health Care, Hall in Tyrol/ Innsbruck/ Salt Lake City, Austria, (6)UMIT, Dept. Public Health&HTA/ ONCOTYROL, Area 4 HTA&Bioinformatics/ Harvard School Public Health, Center for Health Decision Science, Dept. Health Policy&Management/ Harvard Medical School, Institute for Technology Assessment&Dept. Radiology, Hall in Tyrol/ Innsbruck/ Boston, Austria
PS4-18

REGORAFENIB USE IN METASTATIC COLORECTAL CANCER AFTER FAILING ALL APPROVED LINES OF THERAPY: ADEQUATE QUALITY OF LIFE AND COST-EFFECTIVE?
Melissa Robins, MS1, Wen Wee Ma, MD1 and James G. Dolan, MD2, (1)Roswell Park Cancer Institute, Buffalo, NY, (2)University of Rochester, Rochester, NY
PS4-19

COST AND COMPARATIVE EFFECTIVENESS OF A GENOMIC CLASSIFIER FOR PROSTATE CANCER TREATMENT DECISIONS
Jennifer E. Mason, PhD1, Adam Dicker, MD, PhD2, Christine Buerki, PhD3, Elai Davicioni, PhD3, Robert Den, MD2 and Timothy Showalter, MD1, (1)University of Virginia, Charlottesville, VA, (2)Thomas Jefferson University, Philadelphia, PA, (3)GenomeDx Biosciences Inc., Vancouver, BC, Canada
PS4-20

* A FUZZY-TRACE THEORY INTERVENTION TO REDUCE DISTRESS FROM POSITIVE MAMMOGRAPHY SCREENING RESULTS
Priscila G. Brust-Renck, M.A., Valerie Reyna, PhD, Evan A. Wilhelms, M.S., Amrita Rao, B.A. and Katie Blitsman, B.A., Cornell University, Ithaca, NY
PS4-21

* MEASURING CANCER RISK PERCEPTION DURING YOUNG ADULTHOOD: A PERCEIVED TEMPORAL SUSCEPTIBILITY TO CANCER
Georges Khalil, BS, MPH, University of Texas MD Anderson Cancer Center, Houston, TX
PS4-22

ASSESSING THE COST-EFFECTIVENESS OF HBA1C TESTING IN THE DIAGNOSIS OF TYPE II DIABETES AND THE IMPACT OF AN IMPERFECT DIAGNOSTIC REFERENCE STANDARD
Arlene Vogan, MHEP, Camille Schubert, MHEP, Jacqueline Parsons, MPH, Judy Morona, PhD and Tracy Merlin, MPH, Adelaide Health Technology Assessment, University of Adelaide, Adelaide, Australia
PS4-23

COLON CANCER SCREENING AMONG US ADULTS AGED 65 AND OLDER: THE INFLUENCE OF LIFE EXPECTANCY AND AGE
Mara A. Schonberg, MD, MPH, Beth Israel Deaconess Medical Center, Brookline, MA, Keith Bellizzi, PhD, MPH, University of Connecticut, Storrs, CT, Erica Breslau, PhD, National Cancer Institute, Bethesda, MD and Ellen P. McCarthy, PhD, MPH, Division of General Medicine and Primary Care, Brookline, MA
PS4-24

* DEVELOPMENT AND USABILITY TESTING OF AN INTERACTIVE WEB-BASED DECISION AID FOR THE TREATMENT OF LOW-AND INTERMEDIATE RISK PROSTATE CANCER
Romy R.E.D. Lamers, MD1, Maarten Cuypers, MSc.2, Marieke de Vries, PhD.2, Lonneke V. van de Poll-Franse, PhD.2 and Paul J.M. Kil, MD, PhD.1, (1)St. Elisabeth Hospital, Tilburg, Netherlands, (2)Tilburg University, Tilburg, Netherlands
PS4-25

USE OF A PERSONALIZED MEDICINE, GENE EXPRESSION SCORE INFLUENCED DECISION MAKING AROUND REFERRAL TO CARDIOLOGY AMONG FEMALE PATIENTS PRESENTING TO PRIMARY CARE WITH SYMPTOMS SUGGESTIVE OF OBSTRUCTIVE CORONARY ARTERY DISEASE
Joseph Ladapo, MD, PhD1, David Sharp, DO2, Bruce Maniet, DO3, Linda Ross, MPH4, John Blanchard, PhD4 and Mark Monane, MD, MS4, (1)New York University School of Medicine, New York, NY, (2)Doctors for Health, Omaha, NE, (3)Bells Medical Clinic, Bells, TX, (4)CardioDx, Inc., Palo Alto, CA
PS4-26

* DECISIONAL CONFLICT IN PROSTATE CANCER TREATMENT DECISION MAKING: HOW EFFECTIVE IS INFORMATION PROVISION?
Maarten Cuypers, MSc.1, Romy R.E.D. Lamers, MD2, Marieke de Vries, PhD.1, Olga Husson, PhD1, Lonneke V. van de Poll-Franse, PhD.1 and Paul J.M. Kil, MD, PhD.2, (1)Tilburg University, Tilburg, Netherlands, (2)St. Elisabeth Hospital, Tilburg, Netherlands
PS4-27

ECONOMIC AND CLINICAL IMPACT OF SWITCHING FROM ANTIMUSCARINICS TO MIRABEGRON FOR THE TREATMENT OF OVERACTIVE BLADDER
Robert Klein, BSIE, MS1, Daniel Bin Ng, PharmD, MBA2, Sinem Perk, PhD1, Ronald Wielage, MA, MPH1, Timothy Klein, BS1, Thomas Yuran, PharmD2 and Todd Berner, MD2, (1)Medical Decision Modeling, Inc., Indianapolis, IN, (2)Astellas Scientific and Medical Affairs, Inc., Northbrook, IL
PS4-28

PREDICTIVE META-MODELING TO QUANTIFY FUTURE HEALTH RISK AND IDENTIFY INDIVIDUALS FOR CLINICAL PROGRAMS AIMED AT IMPROVING HEALTH OUTCOMES AND QUALITY OF CARE
Sandy Chiu, MS, Hamed Zahedi, PhD and Vipin Gopal, PhD, Humana, Louisville, KY
PS4-29

HOW INFORMATION ON TIMING OF GLUCOSE AND BLOOD PRESSURE CONTROL AFFECTS PATIENT DECISION-MAKING IN DIABETES: THE ON-TIME STUDY
Neda Laiteerapong, MD, MS, Paige Fairchild, MPH, Michael Quinn, PhD, William Dale, MD, PhD, Aviva Nathan, MPH and Elbert S. Huang, MD, MPH, University of Chicago, Chicago, IL
PS4-30

TREATMENT DECISIONS IN PRIMARY CARE FOR VETERANS WITH UPPER RESPIRATORY INFECTIONS: A CRITICAL DECISION METHOD
Jorie Butler, PhD1, Barbara Jones, MD2, Kavitha Damal, PhD3, Makoto Jones, MD1 and Matthew Samore, MD4, (1)VHA Salt Lake CIty and University of Utah, Salt Lake City, UT, (2)VHA Salt Lake City, University of Utah, and Intermountain Health Care, Salt Lake City, UT, (3)Salt Lake City VA and University of Utah, Salt Lake City, UT, (4)University of Utah, Salt Lake City, UT. VA Salt LAke City Health Care System, SLC, UT, Salt Lake City, UT
PS4-31

* INCORPORATING STAKEHOLDER PREFERENCES INTO THE DEVELOPMENT AND PRESENTATION OF VALUE OF INFORMATION (VOI) ANALYSES TO INFORM REAL-WORLD RESEARCH INVESTMENT DECISIONS IN A US CANCER CLINICAL TRIALS GROUP
Carrie Bennette, MPH1, Anirban Basu, PhD2, Scott Ramsey, MD, PhD3, David Veenstra, PharmD, PhD1 and Josh Carlson, MPH, PhD1, (1)University of Washington, Seattle, WA, (2)Department of Health Services, University of Washington, Seattle, Seattle, WA, (3)Hutchinson Center for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center / University of Washington, Seattle, WA
PS4-32

* STATISTICAL MODELING AND SENSITIVITY ANALYSIS WITH SPARSE DATA IN OROPHARYNGEAL CANCER: CHALLENGES AND SOLUTIONS
Ahmad K Aljadaan, M.S.1, John H Gennari, Ph.D.1, Mark H. Phillips, Ph.D.2 and Wade Smith, PhD3, (1)Department of Biomedical Informatics and Health Education, University of Washington, Seattle, WA, (2)Department of Radiation Oncology, University of Washington, Seattle, WA, (3)UW, Seattle, WA
PS4-33

* FINANCIAL BURDEN AND IMPOVERISHMENT DUE TO CARDIOVASCULAR MEDICINES IN LOW AND MIDDLE INCOME COUNTRIES, AN ANALYSIS WITH ILLUSTRATION FROM INDIA
Kiran Pandey, MD and David Meltzer, MD/PhD, University of Chicago, Chicago, IL
PS4-34

* ADVANCING METHODS OF HTA: OPTIMISING MONITORING TESTS TO MEET VALUE TARGETS
Philip Akude, MSc, Mike Paulden, MA., MSc. and Christopher McCabe, PhD, University of Alberta, Edmonton, AB, Canada
PS4-35

PATIENTS' TRUST FOR INVOLVEMENT IN SHARED DECISION MAKING: A LONGITUDINAL STUDY
Pei-Shan Su, student1, Ting Teng, student1, Che-Hsin Hsu, student1 and Chi-Chang Chang, PhD2, (1)chungshan medical university, TAICHUNG, Taiwan, (2)ChungShan Medical University, Taichung, Taiwan
PS4-36

* NO CHANGE IN PRIMARY HEALTH CARE COST AMONG PEOPLE WITH IBS IN THE TWO YEARS FOLLOWING REFERRAL TO A GASTROENTEROLOGIST: A UK DATABASE COHORT STUDY
Caroline Canavan, MBChB, MSc, Joe West, MBBS, PhD and Timothy Card, MBBS, PhD, University of Nottingham, Nottingham, United Kingdom
PS4-37

IMPACT OF INTERVENTIONS TO REDUCE BLEEDING ON THE COST-EFFECTIVENESS OF STEMI MANAGEMENT STRATEGIES IN NON-URBAN COMMUNITIES
Brian J. Potter, MDCM, SM, Beth Israel Deaconess Medical Center, Boston, MA and Thomas Gaziano, MD, MSc, Harvard Medical School, Boston, MA
PS4-38

COMPARATIVE EFFECTIVENESS RESEARCH TO INFORM QUALITY IMPROVEMENT USING LINKED COSTS, OUTCOMES, AND PROCESS DATA
Andrew Partington, BSc, (Hons)1, Matthew Horsfall, RN2, Derek Chew, MBBS, MPH, FRACP3, David Ben-Tovim, MBBS, PhD3, Paul Hakendorf, BSc, MPH4 and Jonathan Karnon, PhD1, (1)University of Adelaide, Adelaide, Australia, (2)South Australian Health and Medical Research Institute, Adelaide, Australia, (3)Flinders University, Adelaide, Australia, (4)Flinders Medical Centre, Adelaide, Australia
PS4-39

* BURDEN OF CANCER-ATTRIBUTABLE INFECTIONS IN THE US: ANALYSIS FROM NATIONAL POPULATION-BASED SURVEYS (1999-2012)
Kevin Moore, BA1, Erin Dunn, BA1, Qingyun Liu, MSc1, Stacey Tannenbaum, PhD2 and Tulay Koru-Sengul, MHS, PhD3, (1)University of Miami Miller School of Medicine, Miami, FL, (2)University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, (3)University of Miami Miller School of Medicine, Department of Public Health Sciences, Sylvester Comprehensive Cancer Center, Miami, FL
PS4-40

* A BUDGET IMPACT MODEL FOR A PROGRAM TO INCREASE COLORECTAL CANCER SCREENING
Tong Han Chung, MPH1, Ashish Deshmukh, MPH2, David Lairson, PhD1 and Victoria Champion, PhD, RN, FAAN3, (1)School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, (2)Department of Health Service and Research, MD Anderson Cancer Center, Houston, TX, (3)School of Nursing, Indiana University, Indianapolis, IN
PS4-41

PERCEPTIONS OF COSTS AND BENEFITS AS PREDICTORS OF POSITIVE OUTCOMES IN A BEHAVIORAL INTERVENTION FOR AFRICAN-AMERICAN TEENS
Justin B. Ingels, MS, MPH, College of Public Health, University of Georgia, Athens, GA and Phaedra S. Corso, PhD, College of Public Health, Athens, GA
PS4-42

THE COST-EFFECTIVENESS OF TARGETING HIV PRE-EXPOSURE PROPHYLAXIS BASED ON PARTNER TREATMENT STATUS IN MEN WHO HAVE SEX WITH MEN IN THE US
Aaron Lucas, PhD, MPH1, Bruce R. Schackman, PhD2, Eric Lloyd Ross, AB1, Yazdan Yazdanpanah, MD, PhD3 and A. David Paltiel, PhD4, (1)Massachusetts General Hospital, Boston, MA, (2)Weill Cornell Medical College, New York, NY, (3)Service de maladies Infectieuses et Tropicales, Hôpital Bichat Claude Bernard, Paris, France, (4)Yale School of Public Health, New Haven, CT
PS4-43

A STARTLING LACK OF TRANSPARENCY: A REVIEW OF RECENTLY PUBLISHED MARKOV SCREENING MODELS
Justin B. Ingels, MS, MPH1, Rebecca Walcott, MIP1 and Phaedra S. Corso, PhD2, (1)College of Public Health, University of Georgia, Athens, GA, (2)College of Public Health, Athens, GA
PS4-44

EXTRACTING OPERATING CHARACTERISTICS THAT ARE “BAKED INTO” DISEASE ASSOCIATION MEASURES
Ankur Pandya, PhD, Ajay Gupta, MD and Alvin I. Mushlin, MD, ScM, Weill Cornell Medical College, New York, NY
PS4-45

HEALTH RISK ASSESSMENT SOFTWARE FOR EVERYONE: TESTING THE ASSOCIATION OF NUMERACY WITH ENGAGEMENT, PERCEIVED USEFULNESS AND SATISFACTION
Adam T. Perzynski, PhD1, Misty Harris, MPH2, Gultekin Ozsoyoglu, PhD3, Sandra Andrukat, N/A2 and Joseph J. Sudano, PhD4, (1)Case Western Reserve University at MetroHealth, Cleveland, OH, (2)The MetroHealth System, Cleveland, OH, (3)Case Western Reserve University, Cleveland, OH, (4)Case Western Reserve University at The MetroHealth System, Cleveland, OH
PS4-46

A CULTURALLY-TAILORED BROCHURE TO IMPROVE UNDERSTANDING AMONG WOMEN WITH AN INCOMPLETE MAMMOGRAM RESULT
Erin N. Marcus, M.D., M.P.H., University of Miami Miller School of Medicine, Miami, FL, Tulay Koru-Sengul, MHS, PhD, University of Miami Miller School of Medicine, Department of Public Health Sciences, Sylvester Comprehensive Cancer Center, Miami, FL and Ada Patricia Romilly, MD, Taylor Breast Health Center, Jackson Health System, Miami, FL
PS4-47

* USING OBSERVATIONAL DATA TO EMULATE RANDOMIZED TRIALS OF SURVEILLANCE INTERVENTIONS: AN APPLICATION TO COLORECTAL CANCER
Anders Huitfeldt, MB BCh BAO, Harvard School of Public Health, Boston, MA
PS4-48

INFORMATION NEEDS OF DECISION-MAKERS IN HEALTHCARE: REDUCING THE KNOWLEDGE TO ACTION GAP
Negin N. Fouladi, PhD, MPH, MS, Stephen H. Linder, PhD, Charles E. Begley, PhD and Robert O. Morgan, PhD, University of Texas School of Public Health, Houston, TX
PS4-49

* WHAT IS THE MOST COST-EFFECTIVE STRATEGY FOR TREATING CHRONIC MYELOID LEUKEMIA AFTER IMATINIB LOSES PATENT EXCLUSIVITY IN THE UNITED STATES?
William Padula, Ph.D., Richard Larson, M.D. and Rena Conti, PhD, University of Chicago, Chicago, IL
PS4-50

THE IMPACT OF INFORMATION ABOUT CERVICAL CANCER SCREENING'S SIDE EFFECTS ON INTENTION TO BE SCREENED: A RANDOMIZED SURVEY-BASED STUDY OF NORWEGIAN AND AMERICAN WOMEN
Anita L. Iyer, MPhil1, M. Kate Bundorf, PhD2, Dorte Gyrd-Hansen, PhD3, Jeremy D. Goldhaber-Fiebert, PhD4 and Ivar Sønbø Kristiansen, MD, PhD, MPH1, (1)University of Oslo, Oslo, Norway, (2)Stanford University School of Medicine, Stanford, CA, (3)University of Southern Denmark, Odense, Denmark, (4)Stanford University, Stanford Health Policy, Centers for Health Policy and Primary Care and Outcomes Research, Department of Medicine, Stanford, CA
PS4-51

LONGITUDINAL GLUCOSE LOWERING TREATMENT PATTERNS IN METFORMIN MONOTHERAPY INITIATORS: IMPLICATIONS FROM A REAL-WORLD SETTING
Jennifer Cooper, MPH1, Brian Bartle, MPH2, Min-Woong Sohn, PhD2, Gary Chan, PhD3, Vishal Ahuja, PhD4, Anirban Basu, PhD3 and Elbert S. Huang, MD, MPH1, (1)University of Chicago, Chicago, IL, (2)Center for Management of Complex Chronic Care, Hines, IL, (3)Department of Health Services, University of Washington, Seattle, Seattle, WA, (4)Center on Aging at NORC, University of Chicago, Chicago, IL
PS4-52

ARE PATIENTS' VIEWS AND CULTURAL BACKGROUND TAKEN INTO CONSIDERATION IN THE DEVELOPMENT OF INSTRUMENTS THAT ASSESS SHARED DECISION MAKING OUTCOMES?: A SYSTEMATIC REVIEW TO INFORM RHEUMATOLOGY PRACTICE AND RESEARCH
Karine Toupin April, PhD1, Viviane Grandpierre, MA1, Jennifer Barton, MD2, Liana Fraenkel, MD, MPH3, Linda Li, PhD4, Dawn Stacey, PhD5, France Légaré, MD PhD6, Tamara Rader, MLIS5, Vivian Welch, PhD5, Janet Jull, PhD5, Jennifer O'Neill, MSc5 and Peter Tugwell, MD5, (1)Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada, (2)University of California San Francisco, San Francisco, CA, (3)Yale School of Medicine, New Haven, CT, (4)University of British Columbia, Vancouver, BC, Canada, (5)University of Ottawa, Ottawa, ON, Canada, (6)Université Laval, Quebec City, QC, Canada
PS4-53

* TREATMENT PRACTICES FOR UNCOMPLICATED MALARIAL AT TWO PUBLIC HEALTH FACILITIES IN NIGERIA; IMPLICATIONS ON ADHERENCE TO MALARIAL TREATMENT GUIDELINES
Charles C. Ezenduka, B.Pharm, MBA, MSc, Nnamdi Azikiwe University, Awka, Awka, Nigeria
PS4-54

WHICH COMMUNICATION STRATEGIES IMPACT THE EFFECTIVENESS OF MESSAGES ABOUT MEDICAL EVIDENCE?
Lauren McCormack, PhD, MSPH1, Megan Lewis, PhD2, Cathy Melvin, PhD3, Vanessa Boudewyns, PhD2, Susana Peinado, MA4, Christine E. Kistler, MD, MASc5 and Stacey Sheridan, MD, MPH6, (1)RTI International, Rtp, NC, (2)RTI International, Research Triangle Park, NC, (3)Medical University of South Carolina, Charleston, SC, (4)University of California, Santa Barbara, Santa Barbara, CA, (5)Department of Family Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, (6)Division of General Medicine and Clinical Epidemiology, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC
PS4-55

THE EFFECT OF A VOICE-SITE ON INFORMED CHOICE FOR WOMEN CONSIDERING CERVICAL CANCER SCREENING IN RURAL INDIA: A PHASE II CONTROLLED TRIAL
Lyndal Trevena, MBBS, MPH, PhD1, Rita Isaac, PhD2, Ian Olver, MBBS, PhD1, Madelon Finkel, PhD3, Paul Biswajit, MBBS, PhD4 and HR Prashanth, MBBS, PhD4, (1)University of Sydney, Sydney, Australia, (2)Christian Medical College, Vellore, India, Vellore, India, (3)Weil Cornel Medical College, New York, NY, (4)CMC Vellore, Vellore, India
PS4-56

* PREFERENCES AND PERCEPTIONS OF DECISION-MAKING MODELS BY PERUVIAN MEDICAL STUDENTS
Claudia Zeballos-Palacios, M.D., Research Fellow1, Renato Quispe, M.D., Research Trainee2, Nicole Mongilardi, M.D.2, Carlos Diaz, M.D.3, Carlos Mendez, M.D.4, Natalia Lizárraga, M.D.5, Aldo Paz, M.D.6, Victor M. Montori, MD, MSc1 and Germán Málaga, M.D.7, (1)Knowledge and Evaluation Research Unit - Mayo Clinic, Rochester, MN, (2)CONEVID - Universidad Peruana Cayetano Heredia, Lima, Peru, (3)Universidad Nacional Mayor de San Marcos, Lima, Peru, (4)Universidad Privada Antenor Orrego, Trujillo, Peru, (5)Universidad Católica Santa María, Arequipa, Peru, (6)Universidad Privada Antenor Orrego, Piura, Peru, (7)¨Unidad de Conocimiento y Evidencia¨, Universidad Peruana Cayetano Heredia, Lima, Peru
PS4-57

* HOW DO PATIENT DECISION AIDS FOR PROSTATE CANCER TREATMENT PRESENT INFORMATION?
Prajakta Adsul, MBBS, MPH1, Ricardo Wray, PhD1, Oussama Darwish, MD2, Kyle Spradling, BS2 and Sameer Siddiqui, MD2, (1)Saint Louis University College for Public Health and Social Justice, Saint Louis, MO, (2)Saint Louis University School of Medicine, Saint Louis, MO
PS4-58

AN EXPLORATORY STUDY COMPARING NARRATIVE VERSUS NUMERICAL DISPLAY OF FUNCTIONAL INFORMATION
Robert Dunlea, MD, MS1, Charlene Weir, PhD2, Nancy Staggers, PhD3, Kristina Doing-Harris, PhD4 and Bryan Gibson, PhD2, (1)University of Utah, Salt Lake City, UT, (2)SLC VA IDEAS Center of Innovation, Salt Lake City, UT, (3)University of Maryland, Baltimore, MD, (4)Department of Biomedical Informatics, School of Medicine, Univ of Utah, Salt Lake City, UT
PS4-59

* ADAPTIVE DECISION-MAKING OF BREAST CANCER MAMMOGRAPHY SCREENING: A HEURISTIC REGRESSION-BASED MODEL
Fan Wang, MS, UNIVERSITY OF ARKANSAS, FAYETTEVILLE, AR and Shengfan Zhang, PhD, University of Arkansas, Fayetteville, AR

See more of: The 36th Annual Meeting of the Society for Medical Decision Making

<< Previous Session | Next Session >>